XFLH Capital Corp.

General Information
Business:	(Incorporated in the Cayman Islands) We intend to focus our search initially on target businesses operating in Asia. We may consummate a business combination with an entity located in the People’s Republic of China (including Hong Kong and Macau) (the “PRC” or “China”). Our focus will be on acquiring a middle-market growth business (or more than one business in this category) with a total enterprise value between $200 million and $400 million. We will not consider or undertake an initial business combination with any target company the financial statements of which are audited by an accounting firm that the United States Public Company Accounting Oversight Board (the “PCAOB”) is unable to inspect for two consecutive years. *Yanzhe Yang* has served as our CEO and a director since September 2025. Yanzhe Yang has served as the CEO and founder of Aorui Health Management Co., Ltd. since December 2024. Mr. Yang has multiple years of experience in strategic investment, corporate consulting, and market management. *Tianshi Yang* has served as our CFO since September 2025. Mr. Tianshi Yang has more than 12 years of experience in finance as well as management experience in four Nasdaq-listed companies – SunCar Technology Group Inc. (Nasdaq: SDA); TD Holdings, Inc. (NASDAQ: GLG); Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH), and Meten EdtechX Education Group Ltd. (NASDAQ: METX). The majority of our executive officers and directors are located in or have significant ties to China: – Yanzhe Yang, our CEO and a director, holds Chinese citizenship and resides in China; – Tianshi Yang, our CFO, holds Chinese citizenship and resides in China. – Heung Ming Henry Wong, our independent director nominee, holds Hong Kong citizenship and resides in Hong Kong; – Chennong Huang, our independent director nominee, holds Chinese citizenship and resides in China, and – Jonathan Yee Fung Cheng, our independent director nominee, holds Hong Kong citizenship and resides in Hong Kong. As a result, it may be difficult for investors to effect service of process within the United States on our company, executive officers and directors, or enforce judgments obtained in the United States courts against our company, executive officers and directors. (From the prospectus) (Note: XFLH Capital Corp. filed its S-1 for its SPAC IPO on Sept. 29, 2025, and disclosed the terms: 6 million units at $10.00 each to raise $60 million. Each unit consists of one ordinary share and one right to receive one-seventh (1/7) of an ordinary share upon the consummation of an initial business combination, so you must hold rights in multiples of seven (7) in order to receive shares for all of your rights upon closing of a business combination, as described in more detail in this prospectus).
Industry:	BLANK CHECKS
Employees:	0
Founded:	2025
Contact Information
Address	8 The Green #6565 Dover, DE, 19901
Phone Number	(551) 358-2652
Web Address
View Prospectus:	XFLH Capital Corp.
Financial Information
Market Cap
Revenues	$0 mil (last 12 months)
Net Income	$0 mil (last 12 months)
IPO Profile
Symbol	XFLH
Exchange	NASDAQ
Shares (millions):	6.0
Price range	$10.00 - $10.00
Est. $ Volume	$60.0 mil
Manager / Joint Managers	Maxim Group
CO-Managers
Expected To Trade:
Status:	TBA
Quiet Period Expiration Date:	Available only to Subscribers
Lock-Up Period Expiration Date:	Available only to Subscribers
SCOOP Rating	Available only to Subscribers
Rating Change	Available only to Subscribers

XFLH Capital Corp.

(Incorporated in the Cayman Islands)

We intend to focus our search initially on target businesses operating in Asia. We may consummate a business combination with an entity located in the People’s Republic of China (including Hong Kong and Macau) (the “PRC” or “China”).

Our focus will be on acquiring a middle-market growth business (or more than one business in this category) with a total enterprise value between $200 million and $400 million.

We will not consider or undertake an initial business combination with any target company the financial statements of which are audited by an accounting firm that the United States Public Company Accounting Oversight Board (the “PCAOB”) is unable to inspect for two consecutive years.

Yanzhe Yang has served as our CEO and a director since September 2025. Yanzhe Yang has served as the CEO and founder of Aorui Health Management Co., Ltd. since December 2024. Mr. Yang has multiple years of experience in strategic investment, corporate consulting, and market management.

The majority of our executive officers and directors are located in or have significant ties to China:

– Yanzhe Yang, our CEO and a director, holds Chinese citizenship and resides in China;

– Tianshi Yang, our CFO, holds Chinese citizenship and resides in China.

– Heung Ming Henry Wong, our independent director nominee, holds Hong Kong citizenship and resides in Hong Kong;

– Chennong Huang, our independent director nominee, holds Chinese citizenship and resides in China, and

– Jonathan Yee Fung Cheng, our independent director nominee, holds Hong Kong citizenship and resides in Hong Kong.

As a result, it may be difficult for investors to effect service of process within the United States on our company, executive officers and directors, or enforce judgments obtained in the United States courts against our company, executive officers and directors. (From the prospectus)